Black Cumin Seed and Cancer

Dr. Weeks’ Comment:  Black cumin seed is “heap big medicine”  so eat the seeds and get anti-inflamed!

“It is evident that thymoquinone, the predominant constituent of N. sativa volatile oil has a wide spectrum of favorable effects. In our review we concentrated on four properties of TQ: hepatoprotective, anti-inflammatory, antioxidant and anti-cancer effects, which are supported by evidence-based research elaborating the molecular mechanisms


Thymoquinone: an emerging natural drug with a wide range of medical applications.

Iran J Basic Med Sci. 2014 Dec; 17(12): 950-957.

Mohannad Khader1,* and Peter M Eckl2



Nigella sativa has attracted healers in ancient civilizations and researchers in recent times. Traditionally, it has been used in different forms to treat many diseases including asthma, hypertension, diabetes, inflammation, cough, bronchitis, headache, eczema, fever, dizziness and influenza. Experimentally, it has been demonstrated that N. sativa extracts and the main constituent of their volatile oil, thymoquinone, possess antioxidant, anti-inflammatory and hepatoprotective properties.

In this review we aimed at summarizing the most recent investigations related to a few and most important effects of thymoquinone. It is concluded that thymoquinone has evidently proved its activity as hepatoprotective, anti-inflammatory, antioxidant, cytotoxic and anti-cancer chemical, with specific mechanisms of action, which provide support to consider this compound as an emerging drug. Further research is required to make thymoquinone a pharmaceutical preparation ready for clinical trials.



Nigella sativa L. (Ranunculaceae) (N. sativa) is an annual herbaceous plant native to (and cultivated in) South West Asia, and cultivated and naturalized in Europe and North Africa. N. sativa seeds are commonly known as black cumin, and have been used as a spice and a condiment. In traditional medicine, N. sativa has been used in different forms to treat many diseases including asthma, hypertension, diabetes, inflammation, cough, bronchitis, headache, eczema, fever, dizziness and influenza (1, 2).

Recent research reports conducted in Muslim countries have shown that N. sativa is very commonly used by cancer patients as dietary supplement (DS) in complementary and alternative medicine (CAM) along with chemotherapy (3, 4).

  1. sativa seed extract, fixed oil and essential oil showed a wide spectrum of favorable biological activities, the most prominent being antioxidant (2, 57), anti-inflammatory (2, 8, 9), antibacterial (1012), hepatoprotective (1317), antimutagenic (18, 19) and antitumor (2022) activities.


The plant attracts the interest of researchers all over the world, and a lot of investigations have reported its importance. Searching the database “PubMed” for the keyword, black cumin, gives 645 results, and searching for the keyword, Nigella sativa, gives more than 582 results. In preparing this review article we used the key words, Nigella sativa and thymoquinone, and the most recently published articles are cited in this review.

Constituents of Nigella sativa

  1. sativa seeds contain fixed oil, proteins, alkaloids, saponins, and essential oil. The biological effects of N. sativa are attributed to the various characterized constituents (1). Thymoquinone (TQ), the most prominent constituent of N. sativa seeds essential oil has been intensively investigated, 406 research reports have been posted on the “PubMed” database about TQ since 1960. TQ has been ascribed many properties. In this review a selection of these properties will be discussed (Table 1).
Table 1

Selected pharmacological effects of thymoquinone

Hepatoprotective effects

To investigate the cytoprotective effects of TQ against acetaminophen-induced hepatotoxicity, Wistar albino rats were given 500 mg/kg acetaminophen orally, followed by three doses of TQ at a total dose of 15 mg/kg within an 18 hr time interval (three times 5 mg/kg oral thymoquinone for every six hr). The levels of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), tissue levels of malondialdehyde (MDA), oxidized glutathione (GSSG), and superoxide dismutase (SOD) activity were found to be lower compared to that of rats treated with acetaminophen only. Histopathological studies further revealed significant liver necrosis and toxicity with acetaminophen treatment, whereas those of TQ treatment significantly lowered liver injury scores (23).

Supplementation of TQ (2 mg/kg/day) for 5 days before acetaminophen administration reversed the acetaminophen-induced increase in ALT, total nitrate/nitrite and lipid peroxide, and the decrease of reduced GSH and ATP. TQ was effective in protecting mice against acetaminophen-induced hepatotoxicity possibly via increased resistance to oxidative and nitrosative stress (24).

Treatment with anti-cancer drugs like the alkylating agent 5-(Aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) is associated with significant hepatotoxicity. BALB/c mice transplanted with the mouse mammary cancer cell line (66CL-4-GFP) were treated in vivo with the antitumor drug CB 1954 (141 mg/kg), TQ (10 mg/kg), and a combination of CB 1954 and TQ. Histological examination revealed significant tumor regression and maintenance of the liver enzymes ALT and AST in the combined treatment compared to CB 1954 alone (25). Furthermore, the effects of aqueous extracts of N. sativa seeds (50 mg/kg) or TQ (5 mg/kg in corn oil) applied by gavage for 5 days were investigated on detoxifying enzymes and glutathione by comparing healthy and CCl4-challenged (1 ml/kg in corn oil, intraperitoneally, a single dose) rats. Both N. sativa and TQ reduced the increased levels of serum ALT activity, the levels of oxidized glutathione, and the stress ratio caused by CCl4. Both N. sativa and TQ also ameliorated the reduced messenger RNA (mRNA) levels of glutathione S-transferase (GST), NAD (P) H-quinone oxido-reductase (NQO1), and microsomal epoxide hydrolase (EPHX1), as well as the reductions in reduced glutathione and cysteine levels caused by CCl4. This protection may be attributed to the increased transcription of chemoprotective enzyme mRNAs (26). TQ supplementation also normalized liver reduced glutathione (GSH) and decreased the levels of MDA and caspase-3 activity in the liver, and reduced serum tumor necrosis factor-alpha (TNF-alpha), serum total bilirubin and the activities of alkaline phosphatase (ALP) and gamma-glutamyl transferase (gamma-GT) enzymes. Histopathological examination revealed that TQ administration improved lipopolysaccharide (LPS)-induced pathological abnormalities in liver tissues (27). Summarizing these investigations revealed a protective effect of TQ against the cytotoxicity of different agents in vivo.

No genotoxicity studies have been performed thus far in vivo. Cyto- and genotoxicity evaluation of TQ in primary rat hepatocyte cultures at final concentrations ranging from 1.25 to 20 μM and three hr exposure, in contrast to the in vivo studies, revealed cytotoxicity of TQ as evidenced by increased levels of necrotic cells at concentrations between 2.5 and 20 μM, and gave also evidence for genotoxicity at concentrations ≥1.25 μM using the same assay system (28).

Genoprotective effects of N. sativa and TQ were examined by applying the comet assay. Serum/glucose deprivation-induced DNA damage was significantly decreased in PC12 cells pretreated with N. sativa extract and TQ (29).

For the in vivo cytoprotective studies absolute doses ranging from 2 to 10 mg/kg of animal body weight for a period of 1-5 days were applied (2325). Taking the pharmacodynamics and pharmacokinetics of the compound into consideration, the effective concentration in vivo is certainly lower than the final concentrations applied directly to hepatocyte primary cultures in vitro. Furthermore, an acute treatment like this does not allow any adaptive response, which will gradually establish.

Anti-inflammatory effects

There are many reports on the anti-inflammatory activity of TQ (3050). Kundu et al (30), stated that the anti-inflammatory effect of TQ is caused by the upregulated expression of heme-oxygenase 1 (HO-1) in human keratinocytes (HaCaT) by activating nuclear factor (NF)-erythroid2-(E2)-related factor-2 (Nrf2) via reactive oxygen species (ROS)-mediated phosphorylation of protein kinase B (PKB/Akt) and cyclic AMP-activated protein kinase-alpha (AMPKalpha). According to Bai et al (37), TQ attenuated thioacetamide (TAA)-induced liver fibrosis accompanied by reduced protein and mRNA expression of of α-smooth muscle actin (α-SMA), collagen-I and tissue inhibitor of toll-like receptor 4 (TLR4) and decreased pro-inflammatory cytokine levels. It also inhibited phosphatidylinositol 3-kinase phosphorylation and enhanced the phosphorylation of adenosine monophosphate-activated protein kinase (AMPK) and liver kinase B (LKB).

TQ has also been reported to inhibit the effects of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced expression of cyclooxygenase-2 (COX-2) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) (38). N. sativa and TQ treatment also suppressed the expression of the COX-2 enzyme in the pancreatic tissue of streptozotocin (STZ)-induced diabetic rats (39). The anti-ulcerative effect of N. sativa and TQ was demonstrated by Kanter et al (40, 41) by investigating ethanol induced mucosal ulceration in rats, which was inhibited by pretreatment with TQ and N. sativa. Furthermore, oral administration of TQ in Wistar rats at 5mg/kg body weight for 21 days led to a significant reduction of the levels of different pro-inflammatory mediators (IL-1β, IL-6, TNFα, IFNγ and PGE(2)) (42). Intraperitoneal treatment of mice with thymoquinone (6 mg/kg; IP), 24 and 1 hr before intratracheal treatment with Diesel exhaust particles (DEP) (30 µg/mouse), prevented pulmonary inflammation and the increase of airway resistance caused by DEP, and inhibited the increase of blood leukocyte numbers and plasma IL-6 concentrations (43). The effects of TQ on airway inflammation in a mouse model of allergic asthma were investigated by intraperitoneal injection of TQ before airway challenge of ovalbumin (OVA)-sensitized mice, and caused a marked decrease in lung eosinophilia and elevated Th2 cytokines – both in vivo and in vitro – following stimulation of lung cells with OVA. TQ also decreased the elevated serum levels of OVA-specific IgE and IgG1. Histological examination of lung tissue demonstrated that the compound significantly inhibited allergen-induced lung eosinophilic inflammation and mucus-producing goblet cells (44). Using an asthmatic murine model, TQ has also been demonstrated to have a high potential in inhibiting the inflammatory changes associated with asthma, especially the aggregation of inflammatory cells in bronchoalveolar lavage (BAL) fluid and in lung tissues. In addition it inhibited mRNA expression of inducible nitric oxide synthase (iNOS) and transforming growth factor-β1 (TGF-β1) (45).

In experiments on ovalbumin-sensitized guinea pigs and sulfur mustard exposed guinea pigs, an outstanding evidence of the preventive anti-inflammatory effects of TQ and N. sativa has been reported (4650). Different extracts, mainly aqueous extracts, from N. sativa seeds proved to possess relaxant (bronchodilatory) effects on tracheal chains of guinea pigs (51).

Antioxidant effects

TQ has been intensively studied for its antioxidant effects. Thymoquinone and thymohydroquinone inhibited in vitro non-enzymatic lipid peroxidation in hippocampal homogenates induced by iron-ascorbate (52). Pretreatment of male NMRI rats with TQ and N. sativa oil significantly decreased lipid peroxidation levels measured as MDA in hippocampus portion following cerebral ischemia-reperfusion injury (IRI) (53).

According to Abdel-Wahab and Aly (6), N. sativa oil neutralized the toxicity of aflatoxins, and treatment with N. sativa oil of rats fed an aflatoxin-contaminated diet resulted in significant protection against aflatoxicosis. Recent reports further demonstrate that TQ at a dose of 9 mg/kg body weight protects liver injury induced by aflatoxin B1 (AFB1) as evidenced by a reduction of the serum concentrations of AST, ALT and ALP as marker enzymes for liver injury. When rats were pretreated with TQ followed by AFB1 the GSH content of the liver was restored and MDA production prevented (54). N. sativa oil and its active component, TQ have also been shown to protect brain tissue from radiation-induced nitrosative stress (55). Oral administration of TQ in Wistar rats at 5 mg/kg body weight for 21 days resulted in a significant reduction of the levels of different antioxidant parameters (myeloperoxidase MPO, LPO, GSH, catalase (CAT), SOD and NO) in collagen induced arthritis (CIA) (42), and similarly reduced the Fe(III) nitrilotriacetic acid (Fe-NTA) induced oxidative stress after oral administration in Wistar rats (56). Furthermore, the glycation of SOD by glucose or methylglyoxal (MG) and its protection by TQ has been investigated. Incubation of SOD with glucose at 37ºC resulted in a progressive decrease in the activity of the enzyme due to fragmentation, evidenced by a decrease in the amount of protein on SDS-PAGE gels. On the other hand, incubation of SOD with MG or both glucose and MG glucose at 37ºC caused protein cross linking evidenced by the formation of high molecular weight aggregates. TQ offered protection against glucose or methylglyoxal (MG) induced loss of SOD activity and fragmentation or cross-linking (57). Pretreatment of Wistar rats with TQ and 1,2-dimethylhydrazine (DMH) for 10 weeks prevented the depletion of antioxidant enzymes catalase, glutathione peroxidase, and superoxide dismutase in red blood cells and maintained a similar value as the control group. At the same time, it prevented erythrocyte damage in DMH-induced colon post initiation carcinogenesis in rats (58). TQ and N. sativa oil possess cytoprotective effects against the anti-cancer drugs cyclophosphamide (CTX) via maintenance of hemoglobin and blood sugar levels, and the activities of liver enzymes, bilirubin, urea, creatinine, lipids (triglyceride, cholesterol and low-density lipoprotein (LDL)-cholesterol) and lipid peroxidation in the liver. The cytoprotective effects of N. sativa oil and TQ were associated with induction of antioxidant mechanisms (59). Neuron-protective effects have also been studied in cultured hippocampal and cortical neurons treated with amyloid-β peptide (Aβ1-42) and TQ simultaneously for 72 h. TQ efficiently attenuated Aβ1-42-induced neurotoxicity by improving cell viability. It has also been shown to inhibit mitochondrial membrane potential depolarization and the generation of reactive oxygen species caused by Aβ1-42, and to restore synaptic vesicle recycling inhibition and to partially reverse the loss of spontaneous firing activity, and Aβ1-42 aggregation in vitro (60).

Anti-cancer and antitumor activity

There has been growing interest in natural compounds with anti-cancer properties because they are presumably non-toxic to healthy cells and are available in a readily digestible form. There is a wide consensus in cancer research that TQ has promising anti-cancer activity. Many researchers provided evidence for the chemopreventive or chemotherapeutic activity. Thus it may be useful as a dietary supplement to enhance the effects of anti-cancer drugs.

There is evidence that TQ induces p53-independent apoptosis via the activation of caspase-8 and caspases 9 and 3 in the caspase cascade. Activation of caspase-8 promotes release of cytochrome c from mitochondria into the cytoplasm. It also modulates the Bax/Bcl2 ratio by upregulation of proapoptotic Bax and down-regulation of antiapoptotic Bcl2 proteins in p53-null HL-60 cells during apoptosis (61). Investigating the anti-cancer effects of TQ on A549 non-small cell lung cancer cells exposed to benzo(a)pyrene, Ulasli et al (62) found that TQ treatment up-regulated Bax and down-regulated Bcl2 proteins, and increased the Bax/Bcl2 ratio. It also decreased the expression of cyclin D and increased the expression of p21, and it up-regulated TRAIL receptor 1 and 2 expression. These molecular events lead to regulatory p53 levels affecting the induction of G2/M cell cycle arrest and apoptosis.

In breast cancer cells TQ was able to increase peroxisome proliferator-activated receptor gamma (PPAR-γ) activity and to down-regulate the expression of the genes for Bcl-2, Bcl-xL and survivin. More importantly, the increase in PPAR-γ activity was prevented in the presence of PPAR-γ specific inhibitors and PPAR-γ dominant negative plasmids, suggesting that TQ may act as a ligand of PPAR-γ (63). Treatment of human breast carcinoma in both in vitro and in vivo models demonstrated antiproliferative and proapoptotic effects of TQ, which are mediated by its inductive effect on p38 and ROS signaling. TQ possesses anti-tumor effects in breast tumor xenograft mice and it potentiates the antitumor effect of doxorubicin (64). TQ has also been shown to inhibit the growth of the human cholangiocarcinoma (CCA) cell lines TFK-1 and HuCCT1 in a dose- and time-dependent manner. The mechanism of CCA cell line growth inhibition is exerted by down-regulation of PI3K/Akt and NF-κB, and regulated gene products, including X-linked inhibitor of apoptosis protein (XIAP), vascular endothelial growth factor (VEGF), p-AKT, p65, Bcl-2 and COX-2 (65). TQ also exerts an inhibitory effect on migration of metastatic human (A375) and mouse (B16F10) melanoma cells by inhibition of NLRP3 inflammasome resulting in a decreased proteolytic cleavage of caspase-1. Thus, it can be a potential immunotherapeutic agent not only in adjuvant therapy for melanoma, but also in the control and prevention of metastatic melanoma (66). TQ is also a microtubule-targeting agent (MTA), and binds to the tubulin-microtubule network, thus preventing microtubule polymerization and causing mitotic arrest and apoptosis of A549 cells but not of normal HUVEC cells (67). Investigating the putative anti-cancer activities of TQ on α/β tubulin expression in human astrocytoma cells (cell line U87, solid tumor model) and in Jurkat cells (T lymphoblastic leukaemia cells) evidence was provided for TQ to target the level of α/β tubulin proteins in cancer cells. It induced α/β tubulin in both cancer cell types. The degradation found was associated with the upregulation of the tumor suppressor p73 with subsequent induction of apoptosis. No effect on α/β tubulin protein expression was found in normal human fibroblasts used as control cell model. These data indicate that TQ exerts a selective effect on α/β tubulin in cancer cells (68). Furthermore, TQ effects on human topoisomerase IIα were investigated and demonstrated that it enhances enzyme-mediated DNA cleavage 5-fold, which is similar to the anti-cancer drug etoposide indicating that TQ can be considered as human type II topoisomerase poison (69). The majority of patients with glioblastoma, the most aggressive malignant astrocytic brain tumor in adults, experience a recurrence of the tumor because of these cells` resistance to apoptotic cell death following ionizing radiation and chemotherapy with temozolomide (TMZ), and an increased autophagy, TQ proved to induce caspase-dependent apoptosis and to inhibit autophagy of glioblastoma cells (70). By studying the mechanisms of cytotoxicity on neuroblastoma (Neuro-2a) cells it was additionally found that TQ induces apoptosis by increasing the Bax/Bcl-2 ratio, which leads to the release of cytochrome c from mitochondria into the cytoplasm. TQ treatment also directs the activation of caspase-3 followed by the cleavage of poly (ADP-ribose) polymerase (PARP) and down-regulates the caspase inhibitor XIAP (71).

Cytotoxicity of TQ was also tested in triple-negative breast cancer (TNBC) cells that lack functional tumor suppressor p53. TQ treated cells showed G1 phase cell cycle arrest and apoptosis characterized by the loss of mitochondrial membrane integrity as evidenced by release of cytochrome c and caspase 9 activation (72). Thymoquinone treatment also inhibits the proliferation of multiple myeloma (MM) cells and potentiates the apoptotic effect of bortezomib in various MM cell lines via the activation of caspase-3, resulting in the cleavage of PARP. TQ treatment also inhibits chemotaxis and invasion induced by C-X-C motif chemokine 12 (CXCL12) in MM cells in vitro and a xenograft mouse model (73). TQ treatment inhibits the expression of NF-κB and suppresses IL-8 and its receptors. It increases levels of ROS and mRNAs of the oxidative stress-related genes, NQO1 and HO-1. Pretreatment of HepG2 cells with N-acetylcysteine, a scavenger of ROS, prevented TQ-induced cell death. TQ treatment also stimulated mRNA expression of pro-apoptotic Bcl-xS and TRAIL death receptors, and inhibited expression of the anti-apoptotic gene Bcl-2. Conclusively, TQ enhanced TRAIL-induced death of HepG2 cells, in part by upregulating TRAIL death receptors, inhibiting NF-κB and IL-8 and stimulating apoptosis. These manifold molecular mechanisms of TQ-dependent suppression of HCC cell growth underscore the potential of this compound as anti-HCC drug (74).

Go to:


In conclusion, it is evident that thymoquinone, the predominant constituent of N. sativa volatile oil has a wide spectrum of favorable effects. In our review we concentrated on four properties of TQ: hepatoprotective, anti-inflammatory, antioxidant and anti-cancer effects, which are supported by evidence-based research elaborating the molecular mechanisms. These beneficial effects of thymoquinone support the use of this natural compound as a drug with a wide range of medical applications. Further clinical research is required to confirm its benefits and efficacy as pharmaceutical preparation.

Go to:


  1. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003;17:299-305. [PubMed]
  2. Entok E, Ustuner MC, Ozbayer C, Tekin N, Akyuz F, Yangi B, et al. Anti-inflammatuar and anti-oxidative effects of Nigella sativa L. FDG-PET imaging of inflammation. Mol Biol Rep. 2014;41:2827-2834. [PubMed]
  3. Jazieh AR, Al Sudairy R, Abulkhair O, Alaskar A, Al Safi F, Sheblaq N, et al. Use of complementary and alternative medicine by patients with cancer in Saudi Arabia. J Altern Complement Med. 2012;8:1045-1049. [PubMed]
  4. Mayadagli A, Aksu A, Goksel F, Gocen E, Karahacioglu E, Gumus M, et al. Determination of parameters affecting the use of complementary and alternative medicine in cancer patients and detection of prevalence of use. Afr J Tradit Complement Altern Med. 2011;8:477-482. [PMC free article] [PubMed]
  5. Soleimani H, Ranjbar A, Baeeri M, Mohammadirad A, Khorasani R, Yasa N, et al. Rat plasma oxidation status after Nigella sativa L. botanical treatment in CCL(4)-treated rats. Toxicol Mech Methods. 2008;18:725-731. [PubMed]
  6. Abdel-Wahhab MA, Aly SE. Antioxidant property of Nigella sativa (black cumin) and Syzygium aromaticum (clove) in rats during aflatoxicosis. J Appl Toxicol. 2005;25:218-223. [PubMed]
  7. Ashraf SS, Rao MV, Kaneez FS, Qadri S, Al-Marzouqi AH, Chandranath IS, et al. Nigella sativa extract as a potent antioxidant for petrochemical-induced oxidative stress. J Chromatogr Sci. 2011;49:321-326. [PubMed]
  8. El-Dakhakhny M, Madi NJ, Lembert N, Ammon HP. Nigella sativa oil, nigellone and derived thymoquinone inhibit synthesis of 5-lipoxygenase products in polymorphonuclear leukocytes from rats. J Ethnopharmacol. 2002;81:161-164. [PubMed]
  9. Hajhashemi V, Ghannadi A, Jafarabadi H. Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug. Phytother Res. 2004;18:195-199. [PubMed]
  10. Bakathir HA, Abbas NA. Detection of the antibacterial effect of Nigella sativa ground seeds with water. Afr J Tradit Complement Altern Med. 2011;8:159-164. [PMC free article] [PubMed]
  11. Chaieb K, Kouidhi B, Jrah H, Mahdouani K, Bakhrouf A. Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation. BMC Complement Altern Med. 2011;11:29. [PMC free article] [PubMed]
  12. Kokoska L, Havlik J, Valterova I, Sovova H, Sajfrtova M, Jankovska I. Comparison of chemical composition and antibacterial activity of Nigella sativa seed essential oils obtained by different extraction methods. J Food Prot. 2008;71:2475-2480. [PubMed]
  13. Al-Suhaimi EA. Hepatoprotective and immunological functions of Nigella sativa seed oil against hypervitaminosis A in adult male rats. Int J Vitam Nutr Res. 2012;82:288-297. [PubMed]
  14. Daba MH, Abdel-Rahman MS. Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicol Lett. 1998;95:23-29. [PubMed]
  15. Hassan AS, Ahmed JH, Al-Haroon SS. A study of the effect of Nigella sativa (Black seeds) in isoniazid (INH)-induced hepatotoxicity in rabbits. Indian J Pharmacol. 2012;44:678-682. [PMC free article] [PubMed]
  16. Michel CG, El-Sayed NS, Moustafa SF, Ezzat SM, Nesseem DI, El-Alfy TS. Phytochemical and biological investigation of the extracts of Nigella sativa L. seed waste. Drug Test Anal. 2011;3:245-254. [PubMed]
  17. Talib WH, Abukhader MM. Combinatorial effects of thymoquinone on the anti-cancer activity and hepatotoxicity of the prodrug CB 1954. Sci Pharm. 2013;81:519-530. [PMC free article] [PubMed]
  18. Bourgou S, Ksouri R, Bellila A, Skandrani I, Falleh H, Marzouk B. Phenolic composition and biological activities of Tunisian Nigella sativa L. shoots and roots. C R Biol. 2008;331:48-55. [PubMed]
  19. Khader M, Bresgen N, Eckl PM. Antimutagenic effects of ethanolic extracts from selected Palestinian medicinal plants. J Ethnopharmacol. 2010;127:319-324. [PubMed]
  20. Aikemu A, Xiaerfuding X, Shiwenhui C, Abudureyimu M, Maimaitiyiming D. Immunomodulatory and anti-tumor effects of Nigella glandulifera freyn and sint seeds on ehrlich ascites carcinoma in mouse model. Pharmacogn Mag. 2013;9:187-191. [PMC free article] [PubMed]
  21. Arafa e Zhu Q, Shah ZI, Wani G, Barakat BM, Racoma I, et al. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. Mutat Res. 2011;706:28-35. [PMC free article] [PubMed]
  22. Majdalawieh AF, Hmaidan R, Carr RI. Nigella sativa modulates splenocyte proliferation, Th1/Th2 cytokine profile, macrophage function and NK anti-tumor activity. J Ethnopharmacol. 2010;131:268-275. [PubMed]
  23. Aycan IO, Tufek A, Tokgoz O, Evliyaoglu O, Firat U, Kavak GO, et al. Thymoquinone treatment against acetaminophen-induced hepatotoxicity in rats. Int J Surg. 2014;12:213-218. [PubMed]
  24. Nagi MN, Almakki HA, Sayed-Ahmed MM, Al-Bekairi AM. Thymoquinone supplementation reverses acetaminophen-induced oxidative stress, nitric oxide production and energy decline in mice liver. Food Chem Toxicol. 2010;48:2361-2365. [PubMed]
  25. Talib WH, Abukhader MM. Combinatorial effects of thymoquinone on the anti-cancer activity and hepatotoxicity of the prodrug CB 1954. Sci Pharm. 2013;81:519-530. [PMC free article] [PubMed]
  26. El-Sayed WM. Upregulation of chemoprotective enzymes and glutathione by Nigella sativa (black seed) and thymoquinone in CCl4-intoxicated rats. Int J Toxicol. 2011;30:707-714. [PubMed]
  27. Helal GK. Thymoquinone supplementation ameliorates acute endotoxemia-induced liver dysfunction in rats. Pak J Pharm Sci. 2010;23:131-137. [PubMed]
  28. Khader M, Bresgen N, Eckl PM. In vitro toxicological properties of thymoquinone. Food Chem Toxicol. 2009;47:129-133. [PubMed]
  29. Babazadeh B, Sadeghnia HR, Safarpour Kapurchal E, Parsaee H, Nasri S, Tayarani-Najaran Z. Protective effect of Nigella sativa and thymoquinone on serum/glucose deprivation-induced DNA damage in PC12 cells. Avicenna J Phytomed. 2012;2:125-132. [PMC free article] [PubMed]
  30. Kundu J, Kim DH, Kundu JK, Chun KS. Thymoquinone induces heme oxygenase-1 expression in HaCaT cells via Nrf2/ARE activation: Akt and AMPKalpha as upstream targets. Food Chem Toxicol. 2014;65:18-26. [PubMed]
  31. Rifaioglu MM, Nacar A, Yuksel R, Yonden Z, Karcioglu M, Zorba OU, et al. Antioxidative and anti-inflammatory effect of thymoquinone in an acute Pseudomonas prostatitis rat model. Urol Int. 2013;91:474-481. [PubMed]
  32. Alemi M, Sabouni F, Sanjarian F, Haghbeen K, Ansari S. Anti-inflammatory effect of seeds and callus of Nigella sativa L. extracts on mix glial cells with regard to their thymoquinone content. AAPS Pharm Sci Tech. 2013;14:160-167. [PMC free article] [PubMed]
  33. Lei X, Liu M, Yang Z, Ji M, Guo X, Dong W. Thymoquinone prevents and ameliorates dextran sulfate sodium-induced colitis in mice. Dig Dis Sci. 2012;57:2296-2303. [PubMed]
  34. Yang W, Bhandaru M, Pasham V, Bobbala D, Zelenak C, Jilani K, et al. Effect of thymoquinone on cytosolic pH and Na+/H+exchanger activity in mouse dendritic cells. Cell Physiol Biochem. 2012;29:21-30. [PubMed]
  35. Woo CC, Kumar AP, Sethi G, Tan KH. Thymoquinon: potential cure for inflammatory disorders and cancer. Biochem Pharmacol. 2012;83:443-451. [PubMed]
  36. Chehl N, Chipitsyna G, Gong Q, Yeo CJ, Arafat HA. Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford) 2009;11:373-381. [PMC free article] [PubMed]
  37. Bai T, Yang Y, Wu YL, Jiang S, Lee JJ, Lian LH, et al. Thymoquinone alleviates thioacetamide-induced hepatic fibrosis and inflammation by activating LKB1-AMPK signaling pathway in mice. Int Immunopharmacol. 2014;19:351-357. [PubMed]
  38. Kundu JK, Liu L, Shin JW, Surh YJ. Thymoquinone inhibits phorbol ester-induced activation of NF-kappaB and expression of COX-2, and induces expression of cytoprotective enzymes in mouse skin in vivo. Biochem Biophys Res Commun. 2013;438:721-727. [PubMed]
  39. Al Wafai RJ. Nigella sativa and thymoquinone suppress cyclooxygenase-2 and oxidative stress in pancreatic tissue of streptozotocin-induced diabetic rats. Pancreas. 2013;42:841-849. [PubMed]
  40. Kanter M, Demir H, Karakaya C, Ozbek H. Gastroprotective activity of Nigella sativa L oil and its constituent, thymoquinone against acute alcohol-induced gastric mucosal injury in rats. World J Gastroenterol. 2005;11:6662-6666. [PMC free article] [PubMed]
  41. Kanter M, Coskun O, Uysal H. The antioxidative and antihistaminic effect of Nigella sativa and its major constituent, thymoquinone on ethanol-induced gastric mucosal damage. Arch Toxicol. 2006;80:217-224. [PubMed]
  42. Umar S, Zargan J, Umar K, Ahmad S, Katiyar CK, Khan HA. Modulation of the oxidative stress and inflammatory cytokine response by thymoquinone in the collagen induced arthritis in Wistar rats. Chem Biol Interact. 2012;197:40-46. [PubMed]
  43. Nemmar A, Al-Salam S, Zia S, Marzouqi F, Al-Dhaheri A, Subramaniyan D, et al. Contrasting actions of diesel exhaust particles on the pulmonary and cardiovascular systems and the effects of thymoquinone. Br J Pharmacol. 2011;164:1871-1882. [PMC free article] [PubMed]
  44. El Gazzer M, El Mezayen R, Nicolls MR, Marecki JC, Dreskin SC. Down-regulation of leukotriene biosynthesis by thymoquinone attenuates airway inflammation in a mouse model of allergic asthma. Biochim Biophys Acta. 2006;1760:1088-1095. [PubMed]
  45. Ammar El SM, Gameil NM, Shawky NM, Nader MA. Comparative evaluation of anti-inflammatory properties of thymoquinone and curcumin using an asthmatic murine model. Int Immunopharmacol. 2011;11:2232-2236. [PubMed]
  46. Boskabady MH, Kiani S, Jandaghi P, Ziaei T, Zarei A. Antitussive effect of Nigella Sativa in Guinea Pigs. Pak J Med Sci. 2004;20:224-228.
  47. Keyhanmanesh R, Boskabady MH, Khamneh S, Doostar Y. Effect of thymoquinone on the lung pathology and cytokine levels of ovalbumin-sensitized guinea pigs. Pharmacological Reports. 2010;62:910-916. [PubMed]
  48. Keyhanmanesh R, Boskabady MH, Eslamizadeh MJ, Khamneh S, Ebrahimi MA. The effect of thymoquinone, the main constituent of Nigella sativa on tracheal responsiveness and white blood cell count in lung lavage of sensitized guinea pigs. Planta Medica. 2010;76:218-222. [PubMed]
  49. Boskabady MH, Keyhanmanesh R, Khameneh S, Doostdar Y, Khakzad MR. Potential immunomodulation effect of the extract of Nigella sativa on ovalbumin sensitized guinea pigs. J Zhejiang Univ-Sci B. 2011;12:201-209. [PMC free article] [PubMed]
  50. Boskabady MH, Vahedi N, Amery S, Khakzad MR. The effect of Nigella sativa alone, and in combination with dexamethasone, on tracheal muscle responsiveness and lung inflammation in sulfur mustard exposed guinea pigs. J Ethnopharmacol. 2011;137:1028-1034. [PubMed]
  51. Keyhanmanesh R, Boskabady MH, Ebrahimi Saadatloo MA, Khamnei S. The contribution of water and lipid soluble substances in the relaxant effects of Nigella sativa extract on guinea pig tracheal smooth muscle (in vitro) Iran J Basic Med Sci. 2007;10:154-161. [PubMed]
  52. Al-Majed AA, Al-Omar FA, Nagi MN. Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus. Eur J Pharmacol. 2006;543:40-47. [PubMed]
  53. Hosseinzadeh H, Parvardeh S, Asl MN, Sadeghnia HR, Ziaee T. Effect of thymoquinone and Nigella sativa seeds oil on lipid peroxidation level during global cerebral ischemia-reperfusion injury in rat hippocampus. Phytomedicine. 2007;14:621-627. [PubMed]
  54. Nili-Ahmadabadi A, Tavakoli F, Hasanzadeh G, Rahimi H, Sabzevari O. Protective effect of pretreatment with thymoquinone against Aflatoxin B(1) induced liver toxicity in mice. Daru. 2011;19:282-287. [PMC free article] [PubMed]
  55. Ahlatci A, Kuzhan A, Taysi S, Demirtas OC, Alkis HE, Tarakcioglu M, et al. Radiation-modifying abilities of Nigella sativa and thymoquinone on radiation-induced nitrosative stress in the brain tissue. Phytomedicine. 2014;21:740-744. [PubMed]
  56. Khan N, Sultana S. Inhibition of two stage renal carcinogenesis, oxidative damage and hyperproliferative response by Nigella sativa. Eur J of Cancer Prev. 2005;1:159-168. [PubMed]
  57. Khan MA, Anwar S, Aljarbou AN, Al-Orainy M, Aldebasi YH, Islam S, et al. Protective effect of thymoquinone on glucose or methylglyoxal-induced glycation of superoxide dismutase. Int J Biol Macromol. 2014;65:16-20. [PubMed]
  58. Harzallah HJ, Grayaa R, Kharoubi W, Maaloul A, Hammami M, Mahjoub T. Thymoquinone, the Nigella sativa bioactive compound, prevents circulatory oxidative stress caused by 1, 2-dimethylhydrazine in erythrocyte during colon postinitiation carcinogenesis. Oxid Med Cell Longev 2012. 2012 854065. [PMC free article] [PubMed]
  59. Alenzi FQ, El-Bolkiny Y, Salem ML. Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anti-cancer drug cyclophosphamide. Br J Biomed Sci. 2010;67:20-28. [PubMed]
  60. Alhebshi AH, Gotoh M, Suzuki I. Thymoquinone protects cultured rat primary neurons against amyloid beta-induced neurotoxicity. Biochem Biophys Res Commun. 2013;433:362-367. [PubMed]
  61. El-Mahdy MA, Zhu Q, Wang QE, Wani G, Wani AA. Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells. Int J Cancer. 2005;117:409-417. [PubMed]
  62. Ulasli SS, Celik S, Gunay E, Ozdemir M, Hazman O, Ozyurek A, et al. Anti-cancer effects of thymoquinone, caffeic acid phenethyl ester and resveratrol on A549 non-small cell lung cancer cells exposed to benzo(a)pyrene. Asian Pac J Cancer Prev. 2013;14:6159-6164. [PubMed]
  63. Woo CC, Loo SY, Gee V, Yap CW, Sethi G, Kumar AP, et al. Anti-cancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-gamma pathway. Biochem Pharmacol. 2011;82:464-475. [PubMed]
  64. Woo CC, Hsu A, Kumar AP, Sethi G, Tan KH. Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS. PLoS One. 2013;8:e75356. [PMC free article] [PubMed]
  65. Xu D, Ma Y, Zhao B, Li S, Zhang Y, Pan S, et al. Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-kappaB pathways in human cholangiocarcinomas both in vitro and in vivo. Oncol Rep. 2014;31:2063-2070. [PubMed]
  66. Ahmad I, Muneer KM, Tamimi IA, Chang ME, Ata MO, Yusuf N. Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome. Toxicol Appl Pharmacol. 2013;270:70-76. [PubMed]
  67. Acharya BR, Chatterjee A, Ganguli A, Bhattacharya S, Chakrabarti G. Thymoquinone inhibits microtubule polymerization by tubulin binding and causes mitotic arrest following apoptosis in A549 cells. Biochimie. 2014;97:78-91. [PubMed]
  68. Alhosin M, Ibrahim A, Boukhari A, Sharif T, Gies JP, Augr C, et al. Anti-neoplastic agent thymoquinone induces degradation of alpha and beta tubulin proteins in human cancer cells without affecting their level in normal human fibroblasts. Invest New Drugs. 2012;30:1813-1819. [PubMed]
  69. Ashley RE, Osheroff N. Natural products as topoisomerase II poisons: effects of thymoquinone on DNA cleavage mediated by human topoisomerase II alpha. Chem Res Toxicol. 2014;27:787-793. [PMC free article] [PubMed]
  70. Racoma IO, Meisen WH, Wang QE, Kaur B, Wani AA. Thymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cells. PLoS One. 2013;8:e72882. [PMC free article] [PubMed]
  71. Paramasivam A, Sambantham S, Shabnam J, Raghunandhakumar S, Anandan B, Rajiv R, et al. Anti-cancer effects of thymoquinone in mouse neuroblastoma (Neuro2-a) cells through caspase-3 activation with down-regulation of XIAP. Toxicol Lett. 2012;213:151-159. [PubMed]
  72. Sutton KM, Greenshields AL, Hoskin DW. Thymoquinone, A bioactive component of black caraway seeds, causes G1 phase cell cycle arrest and apoptosis in triple-negative breast cancer cells with mutant p53. Nutr Cancer. 2014;66:408-418. [PubMed]
  73. Siveen KS, Mustafa N, Li F, Kannaiyan R, Ahn KS, Kumar AP, et al. Thymoquinone overcomes chemoresistance and enhances the anti-cancer effects of bortezomib through abrogation of NF-kappaB regulated gene products in multiple myeloma xenograft mouse model. Oncotarget. 2014;5:634-648. [PMC free article] [PubMed]
  74. Ashour AE, Abd-Allah AR, Korashy HM, Attia SM, Alzahrani AZ, Saquib Q, et al. Thymoquinone suppression of the human hepatocellular carcinoma cell growth involves inhibition of IL-8. expression, elevated levels of TRAIL receptors, oxidative stress and apoptosis. Mol Cell Biochem. 2014;389:85-98. [PubMed]


Articles from Iranian Journal of Basic Medical Sciences are provided here courtesy of Mashhad University of Medical Sciences

Leave a Comment

Your email address will not be published. Required fields are marked *